X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 61 filers reported holding X4 PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 2.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $736,421 | -42.1% | 1,269,693 | +38.8% | 0.01% | -37.5% |
| Q1 2024 | $1,271,850 | +176.1% | 915,000 | +66.6% | 0.01% | +166.7% |
| Q4 2023 | $460,586 | -27.9% | 549,300 | -6.3% | 0.00% | -40.0% |
| Q3 2023 | $638,785 | -66.5% | 586,042 | -40.4% | 0.01% | -68.8% |
| Q2 2023 | $1,908,378 | +111.5% | 983,700 | -5.1% | 0.02% | +77.8% |
| Q1 2023 | $902,190 | +1.5% | 1,037,000 | +15.8% | 0.01% | +28.6% |
| Q4 2022 | $889,033 | – | 895,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 311,490 | $3,957,000 | 2.78% |
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $3,959,000 | 2.25% |
| New Leaf Venture Partners, L.L.C. | 285,000 | $3,622,000 | 1.10% |
| BVF INC/IL | 593,474 | $7,543,000 | 0.79% |
| Cormorant Asset Management, LP | 881,681 | $11,206,000 | 0.68% |
| RA Capital Management | 478,107 | $6,077,000 | 0.36% |
| NEA Management Company, LLC | 333,333 | $4,237,000 | 0.35% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 563,741 | $7,165,000 | 0.29% |
| Orbimed Advisors | 936,493 | $11,903,000 | 0.23% |
| SPHERA FUNDS MANAGEMENT LTD. | 47,391 | $602,000 | 0.09% |